BioCentury | Apr 8, 2021
Finance

Venture rounds for Icosavax, Nucleix, Vizgen, Inscripta, Metagenomi and Volastra

...Lilly Asia Ventures, LYFE Capital and MILFAM and existing investors OrbiMed, Aurum Ventures, DSC Investment, OCI...
BioCentury | Oct 3, 2019
Financial News

OrbiMed-led $80M series B to help Adicet bring its γδ cell therapies to the clinic

...cell therapies. New investors include aMoon2 Fund, Regeneron, Johnson & Johnson Innovation - JJDC Inc., OCI...
BioCentury | Mar 4, 2010
Cover Story

A new spin on protegrin

...online Feb. 18, 2010; doi:10.1126/science.1182749 Contact: John A. Robinson, University of Zurich, Zurich, Switzerland e-mail: robinson@oci.uzh.ch...
BioCentury | Mar 4, 2010
Distillery Therapeutics

Indication: Infectious disease

...online Feb. 18, 2010; doi:10.1126/science.1182749 Contact: John A. Robinson, University of Zurich, Zurich, Switzerland e-mail: robinson@oci.uzh.ch...
BioCentury | Oct 16, 2008
Distillery Therapeutics

This Week in Therapeutics

...Saarland University, Saarbrcken, Germany e-mail: rom@mx.uni-saarland.de Contact: Dirk Menche, University of Heidelberg, Heidelberg, Germany e-mail: dirk.menche@oci.uni-heidelberg.de BC...
Items per page:
1 - 5 of 5
BioCentury | Apr 8, 2021
Finance

Venture rounds for Icosavax, Nucleix, Vizgen, Inscripta, Metagenomi and Volastra

...Lilly Asia Ventures, LYFE Capital and MILFAM and existing investors OrbiMed, Aurum Ventures, DSC Investment, OCI...
BioCentury | Oct 3, 2019
Financial News

OrbiMed-led $80M series B to help Adicet bring its γδ cell therapies to the clinic

...cell therapies. New investors include aMoon2 Fund, Regeneron, Johnson & Johnson Innovation - JJDC Inc., OCI...
BioCentury | Mar 4, 2010
Cover Story

A new spin on protegrin

...online Feb. 18, 2010; doi:10.1126/science.1182749 Contact: John A. Robinson, University of Zurich, Zurich, Switzerland e-mail: robinson@oci.uzh.ch...
BioCentury | Mar 4, 2010
Distillery Therapeutics

Indication: Infectious disease

...online Feb. 18, 2010; doi:10.1126/science.1182749 Contact: John A. Robinson, University of Zurich, Zurich, Switzerland e-mail: robinson@oci.uzh.ch...
BioCentury | Oct 16, 2008
Distillery Therapeutics

This Week in Therapeutics

...Saarland University, Saarbrcken, Germany e-mail: rom@mx.uni-saarland.de Contact: Dirk Menche, University of Heidelberg, Heidelberg, Germany e-mail: dirk.menche@oci.uni-heidelberg.de BC...
Items per page:
1 - 5 of 5